COSENTYX (secukinumab)

  • Home
  • COSENTYX (secukinumab)

COSENTYX (secukinumab) Welcome to the official COSENTYX page! Ask your doctor if COSENTYX may be right for you. Community Guidelines

Welcome to the COSENTYX page!

If you want to learn more about COSENTYX, then you came to the right place. We’re excited you’re here, and we encourage you to join the conversation...especially if it’s with your doctor. However, please keep in mind that we work in a regulated industry, which is why we ask that you follow our Community Guidelines outlined below. It also may take us some time to respond to your posts, comments, an

d questions. We appreciate your patience and participation!

1. From time to time, we may share links to informative third-party sites that you may find useful. Novartis Pharmaceuticals Corporation does not endorse and is not responsible for the content of these third-party sites.

2. For your protection, we will remove any posts/comments that contain any personal, proprietary, confidential, sensitive, or nonpublic information, such as your e-mail or phone number.

3. We at Novartis want to provide a respectful and welcoming community for all. Posts/comments that are profane, defamatory, libelous, offensive, abusive, discriminatory, demeaning, disparaging, threatening, repetitive, and/or disruptive to the community, or that contain leetspeak (use of numbers or characters as letters) or are spam (including links), impersonating other people, posting chain letters or pyramid schemes, "spamming" (sending a message more than once), posting or transmitting charity requests or petitions for signatures, and sending unsolicited mass e-mailings, may be removed.

4. We have a responsibility with regard to drug safety reporting. Posts/comments mentioning side effects experienced while taking COSENTYX must be reported to the FDA. Please see the Adverse Events section of our Community Guidelines for more information.

5. We want to ensure COSENTYX is being taken appropriately. Posts/comments about off-label use of COSENTYX will be removed. Off-label use encompasses any use of COSENTYX for treatment outside of use specifically identified in the “Indication” section of the full Prescribing Information.

6. Your doctor is the best resource for medical advice and information when it comes to your health. Please don’t use information on this page to replace conversations with your doctor. Please do not take the page, or any community posts/comments, as medical advice. Likewise, please do not post any medical advice on the page.

7. We must respect our platform and follow Facebook's posting guidelines and Terms of Use. Posts/comments that do not adhere to these terms and guidelines will be removed.

8. For any questions about sponsorships, scholarships, employment, or any other solicitation for services, please refer to the Novartis website (http://bit.ly/28WrO6w) rather than posting on this page.

9. Please don't use our page as a place to promote your product or pitch your services. We reserve the right to remove any links to personal products or services that don’t relate to the mission or purpose of the COSENTYX page.

10. If you post a question or seek out assistance on our page, someone from our team may direct message or otherwise contact you. There is a chance that your post/comment may have included other content not outlined above. Please know that Novartis reserves the right to remove content at its sole discretion. Novartis assumes no responsibility for any user-generated content posted on the COSENTYX page. Novartis is not responsible for obtaining releases or permissions for user-generated content shared on this page. Novartis is not responsible if someone shares user-generated content from Novartis’ social properties on other social media channels. We expect that you will honor others' property rights. Do not post content that infringes someone else's rights. We may remove content if it may violate such rights. We will respond to requests by anyone who notifies us that such rights are being violated. Violation Protocol:
We reserve the right to ban users from the COSENTYX page who violate these Community Guidelines. Please check often for updates, as we reserve the right, at our sole discretion, to modify these Community Guidelines at any time. Your use of this page indicates your acceptance of any revisions to these terms. Also, while these rules cover most common situations, they cannot anticipate everything. Consequently, Novartis reserves the right to take any actions it deems appropriate to ensure this site is not disrupted or abused in any way. If Community Guideline violations continue, the Community Manager may ban the user and report him/her to Facebook. Adverse Events:
If you think that you have had any medical adverse event or reaction from a Novartis product, please talk to your doctor or pharmacist. You are encouraged to report negative side effects of prescription drugs to the FDA directly. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. We also encourage you to call 1-888-NOW-NOVA (1-888-669-6682). Storing and Using Personal Information:

We do not aim to store or use your personal details. However, in the case of an adverse event or product issue you report to us, we’d need to store and use identifying information about you, such as your name, location, health related information or similar in accordance with the applicable laws. This information is required to be submitted to the Novartis Drug Safety department and/or regulatory authorities. In such cases, we are also required to store your personal data for five years for auditing purposes. Please kindly note that we are using third-party service providers to help us manage your comments and messages which means that they, too, would have access to any personal information you share with us. Such third-party service providers are contractually bound to ensure an adequate protection and security of your personal information. Please note that Facebook also has access to information you share with us. For more details, read their Data Policy (http://bit.ly/1u402GA). If you include any potential adverse events in your post, we may need to contact you to find out more information. We will also report this information to Novartis as well as to the FDA. This is due to our responsibility of drug safety reporting. Voices of Inspiration Program:

In an effort to maintain transparency, we ask any paid member of the Voices of Inspiration Program to please identify themselves as a paid Novartis spokesperson in every post. Novartis Employees and Agents:
If you are an employee of Novartis or affiliate or agent of Novartis, please identify yourself as such. Pharmaceutical Industry:
In an effort to maintain transparency, we ask that those who work in the pharmaceutical industry please identify as such by using the hashtag . Please note that this page is for US residents only.

03/06/2025

Hidradenitis Suppurativa can feel overwhelming, but raising awareness helps. Prescribing info: bit.ly/COSEPI

Learn more at bit.ly/41Ug9Ml

01/05/2025

Every month is Psoriatic Arthritis Action Month when you move & feel better. Individual results may vary. Prescribing info: bit.ly/COSEPI

Learn more at bit.ly/48djzNe

24/03/2025

Lily was tired of struggling with HS. She found symptom relief with COSENTYX®.
See Prescribing info bit.ly/COSEPI.

13/03/2025

Talk to a rheumatologist to learn more about COSENTYX taken through IV. Prescribing Info: bit.ly/COSEPI

Learn more at https://bit.ly/4isnQAq

03/12/2024

Please see full Prescribing Information here: bit.ly/COSEPI , including Medication Guide here: http://bit.ly/87HKSA3

IMPORTANT SAFETY INFORMATION
Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.

What is the most important information I should know about COSENTYX?

COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:

Infections
COSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections. Some people have had serious infections while taking COSENTYX, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses. Some people have died from these infections.
• Your doctor should check you for TB before starting treatment with COSENTYX.
• If your doctor feels that you are at risk for TB, you may be treated with medicine for TB before you begin treatment with COSENTYX and during treatment with COSENTYX.
• Your doctor should watch you closely for signs and symptoms of TB during treatment with COSENTYX. Do not use COSENTYX if you have an active TB infection.

Before starting COSENTYX, tell your doctor if you:
• are being treated for an infection
• have an infection that does not go away or that keeps coming back
• have TB or have been in close contact with someone with TB
• think you have an infection or have symptoms of an infection such as: fevers, sweats, or chills; muscle aches; cough; shortness of breath; blood in your phlegm; weight loss; warm, red, or painful skin or sores on your body; diarrhea or stomach pain; burning when you urinate or urinate more often than normal

After starting COSENTYX, call your doctor right away if you have any signs of infection listed above. Do not use COSENTYX if you have any signs of infection unless you are instructed to by your doctor.

What are the possible side effects of COSENTYX?

COSENTYX may cause serious side effects, including:

Serious allergic reactions
Serious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms: feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; skin rash or hives (red, itchy bumps).

If you have a severe allergic reaction, do not give another injection of COSENTYX.

Inflammatory Bowel Disease
New cases of inflammatory bowel disease or “flare-ups” can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn’s disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.

Severe skin reactions that look like eczema can happen during treatment with COSENTYX from days to months after your first dose and can sometimes lead to hospitalization. Your doctor may temporarily stop treatment with COSENTYX if you develop severe skin reactions. Tell your doctor if you have any of the following signs or symptoms: redness or rash; itching; small bumps or patches; your skin is dry or feels like leather; blisters on the hands or feet that ooze or become crusty or skin peeling.

The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory tract infections.

These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.

Before using COSENTYX, tell your doctor if you:
• have any of the conditions or symptoms listed [above] for infections.
• have inflammatory bowel disease (Crohn’s disease or ulcerative colitis).
• are allergic to latex. The needle cap on the COSENTYX Sensoready® pen, and 150 mg/mL and 75 mg/0.5 mL prefilled syringes contains latex.
• have recently received or are scheduled to receive an immunization (vaccine). People who take COSENTYX should not receive live vaccines. Children should be brought up to date with all vaccines before starting COSENTYX.
• have any other medical conditions and all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Keep a list of your medicines to show your healthcare provider and pharmacist when you get a new medicine.
• are pregnant or plan to become pregnant. It is not known if COSENTYX can harm your unborn baby. You and your doctor should decide if you will use COSENTYX.
• are breastfeeding or plan to breastfeed. It is not known if COSENTYX passes into your breast milk.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATIONS

COSENTYX® (secukinumab) is a prescription medicine used to treat:
• people 6 years of age and older with moderate to severe plaque psoriasis (PsO) that involves large areas or many areas of the body, and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light alone or with systemic therapy)
• people 2 years of age and older with active psoriatic arthritis (PsA)
• adults with active ankylosing spondylitis (AS)
• adults with active non-radiographic axial spondyloarthritis (nr-axSpA) and objective signs of inflammation
• people 4 years of age and older with active enthesitis-related arthritis (ERA)
• adults with moderate to severe hidradenitis suppurativa (HS)

29/10/2024

We’re raising awareness about plaque psoriasis and its possible link to psoriatic arthritis. Prescribing info: bit.ly/COSEPI


Learn more at https://bit.ly/33u1f1j

Address


Alerts

Be the first to know and let us send you an email when COSENTYX (secukinumab) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to COSENTYX (secukinumab):

Shortcuts

  • Address
  • Telephone
  • Alerts
  • Contact The Practice
  • Claim ownership or report listing
  • Want your practice to be the top-listed Clinic?

Share

Our Story

Co-Pay: Financial assistance is available for patients taking COSENTYX. Learn about our $0 co-pay* offer and see if you're eligible: bit.ly/COSEFIN

*Limitations apply. For those commercially insured and 18 years or older. Up to a $16,000 annual cap. You will be responsible for any co-pay once limit is reached in a calendar year. This offer is not valid under Medicare, Medicaid, or any other federal or state program. Not valid for cash-paying patients. Novartis reserves the right to rescind, revoke, or amend this program without notice. Enrollment expires 12/31/20.

Injection: Learn more about how to take COSENTYX and watch video demonstrations here: http://bit.ly/2xsNyOz

6/20 T-COS-1391312